DNA 합성 기술 및 서비스 시장 : 합성 방법별, 주요 응용 분야별, 기업 규모별, 주요 지역별

DNA Synthesis Technologies and Services Market Distribution by Method of DNA Synthesis, Key Applications Areas, Company Size, and Key Geographical Regions

US $ 4,799 ￦ 6,928,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 10,105,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 15,302,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 25,986,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 DNA 합성기술 및 서비스 시장 규모는 2035년까지 예측기간 동안 21.6%의 연평균 복합 성장률(CAGR)로, 현재 12억 달러에서 86억 달러로 성장할 것으로 예측되고 있습니다.

시장 세분화 및 기회 분석은 다음 매개변수로 구분됩니다.

DNA 합성 방법별

• 화학적 방법
• 효소적 방법

주요 응용 분야별

• 조사·진단
• 치료제

기업 규모별

• 소규모
• 중규모
• 대기업

주요 지역별

• 북미
• 유럽
• 아시아태평양
• 기타 지역

DNA 합성 기술 및 서비스 시장 : 성장과 동향

인공 DNA 합성의 개념은 유전자 회로 설계, 유전자 공학, 유전체 합성, 유전성 질환의 진단·치료 등 다양한 분야에 널리 영향을 미치고 있습니다. 합성 생물학이 세계의 건강 관리, 농업, 제조업, 환경 문제에 대한 새로운 해결책을 제공할 수 있는 파괴적 기술로서 대두해 온 것은 특필할 가치가 있습니다. 또한, 최근 분자 생물학 분야의 동향은(DNA의 화학 합성에 사용되는) 자동 강인한 화학 물질의 개발과 같은 유전체의 높은 처리량 연구를 가능하게하는 생물 시스템의 엔지니어링에 기여하고 있습니다. 합성 생물학은 차세대 시퀀싱(NGS) 기술에 의해 생성된 시퀀싱 데이터와 결합하여 RNA 및 DNA의 정량적 분석을 가능하게 하며 질병 및 기타 생물학적 현상과 관련된 유전적 변이를 연구할 수 있습니다.

특필해야할 것은 지난 몇 년간의 COVID-19의 보급에 의해 환자에게 강력한 면역 반응을 유도하는 DNA 및 RNA 기반의 백신 개발에 큰 탄력이 붙은 것입니다. CRISPR 기술과 다른 합성 생물학 기술과의 조합은 광범위한 질병 적응증의 표준 치료를 변화시킬 가능성을 보여줍니다.

여러 기업이 독자적인 효소적 DNA 합성 플랫폼을 개발해 기존의 DNA 합성법에 비해 명확한 이점(DNA 단편의 길이를 길게 할 가능성, 접근성, 편리성 향상 등)을 제공합니다. 제3자 플랫폼과 서비스 제공업체에 DNA 합성 및 복제 작업을 위탁하는 것을 선호하고 있습니다. 폭넓은 용도로 DNA에 대한 요구가 높아지고 있기 때문에 DNA 합성 및 DNA 복제 플랫폼 서비스 업계는 예측 기간 중에 주목해야 할 시장 성장을 이룰 가능성이 높다고 생각됩니다.

DNA 합성 기술 및 서비스 시장 : 주요 인사이트력

이 보고서는 DNA 합성 기술과 서비스 시장의 현재 상태를 파악하고 업계 내 잠재적 성장 기회를 확인합니다.

• 현재, 약 65사가 DNA 합성 기술이나 관련 서비스에 필요한 전문 지식을 가지고 있다고 주장하고 있습니다.
• 이러한 기술·서비스 제공업체는 DNA의 합성에 다양한 생물의학 분야에서의 응용이 가능한, 비용 효율적인 방법을 채용하고 있다고 주장하고 있습니다.
• 최근 몇 년간 DNA 합성 기술과 서비스와 관련된 과학 문헌의 출판이 현저하게 증가하고 있으며, 그러한 논문은 50개국 이상에서 출판되고 있습니다.

• DNA 합성 기술과 서비스에 대한 관심 증가는 최근의 파트너십 활동 증가에도 반영되고 있으며, 실제로 2019년부터 2021년에 걸쳐 파트너십 활동은 CAGR18%로 증가했습니다.
• 지난 몇 년 동안 DNA 합성 기술 분야의 연구와 혁신과 관련된 지속적인 노력을 지원하기 위해 150 개의 학술 보조금이 다양한 조직에 수여되었습니다.
• DNA 합성 기술과 서비스 시장의 장래성을 깨달은 여러 투자자들이 지난 5년간 7억 5,000만 달러 이상을 투자하고 있습니다.
• 2016년 이후, DNA 합성 기술에 관련하는 특허가 11,000건 이상 출원/부여되어 있어, 이 업계에 있어서의 지적 재산의 강력한 포트폴리오를 확립하고 있습니다.
• DNA합성서비스 시장은 2035년까지 연률 21.5% 이상의 성장률이 예상되며 합성방법, 응용 분야, 기업 규모, 지역별 성장 기회가 분산될 가능성이 높습니다.

DNA 합성 기술 및 서비스 시장 : 주요 부문

DNA 합성 방법별로는 시장은 화학적 방법과 효소적 방법으로 구분됩니다. 현재 DNA 합성의 화학적 방법이 세계의 DNA 합성 기술 및 서비스 시장에서 가장 큰 점유율을 차지하고 있습니다.

주요 응용 분야별로는 시장은 연구·진단과 치료로 구분됩니다. 현재 연구 및 진단 분야가 세계의 DNA 합성 기술 및 서비스 시장에서 가장 높은 비율을 차지하고 있습니다.

기업 규모별로 시장은 중소기업, 중견기업, 대기업으로 구분됩니다. 현재 DNA 합성기술 및 서비스 시장에서는 대기업 부문이 최대 점유율을 차지하고 있습니다.

주요 지역별로 볼 때 시장은 북미, 유럽, 아시아태평양 및 기타 지역으로 구분됩니다.

본 보고서에서는 세계의 DNA 합성 기술 및 서비스 시장에 대해 조사했으며,, 시장 개요와 함께 DNA 합성 방법별, 주요 응용 분야별, 기업 규모별, 주요 지역별 동향, 시장 진출기업프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제2장 주요 요약

제3장 소개

• 장의 개요
• DNA 합성 소개
• DNA 합성의 구성 요소
• DNA 합성 기술
• DNA 합성의 응용
• 장래의 전망

제4장 시장 개요: DNA 합성 기술과 서비스

• 장의 개요
• DNA 합성 기술과 서비스 : 시장 상황
• DNA 합성 기술 및 서비스: 주요 업계 진출기업

제5장 기업 프로파일

• 장의 개요
• Ajinomoto Bio-Pharma Services
• ATUM
• DNA Script
• Eurofins Genomics
• Gene Universal
• GenScript
• Synbio Technologies

제6장 사례 연구: 올리고뉴클레오티드 제조(조사 및 진단에의 응용)

• 장의 개요
• 연구 및 진단 용도에 중점을 둔 올리고뉴클레오티드 제조업자 : 시장 상황

제7장 사례 연구: 올리고뉴클레오티드 제조업자(치료 용도)

• 장의 개요
• 치료 용도에 중점을 둔 올리고뉴클레오티드 제조업체 : 시장 상황

제8장 파트너십 및 협업

제9장 자금 조달과 투자 분석

제10장 조성금 분석

제11장 출판물 분석

제12장 특허 분석

제13장 DNA 합성 서비스 : 시장 예측 및 기회 분석

• 장의 개요
• 주요 전제와 예측 조사 방법
• 세계의 DNA 합성 서비스 시장(-2035년)
• 북미의 DNA 합성 서비스 시장(-2035년)
• 유럽에서의 DNA 합성 서비스 시장(-2035년)
• 아시아태평양 및 기타 지역의 DNA 합성 서비스 시장(-2035년)

제14장 결론

제15장 부록 1:표 형식 데이터

제16장 부록 II: 기업 및 조직 목록

SHW

영문 목차

영문목차

DNA SYNTHESIS TECHNOLOGIES AND SERVICES MARKET: OVERVIEW

As per Roots Analysis, the global DNA synthesis technologies and services market is estimated to grow from USD 1.20 billion in the current year to USD 8.6 billion by 2035, at a CAGR of 21.6% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Method of DNA Synthesis

• Chemical Method
• Enzymatic Method

Key Applications Areas

• Research & Diagnostics
• Therapeutics

Company Size

• Small
• Mid-Sized
• Large

Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Rest of the World

DNA SYNTHESIS TECHNOLOGIES AND SERVICES MARKET: GROWTH AND TRENDS

The concept of artificial DNA synthesis has a far-reaching impact across multiple areas, including genetic circuit design, genetic engineering, genome synthesis, diagnosis and treatment of genetic diseases. It is worth mentioning that synthetic biology has emerged as a disruptive technology, capable of delivering new solutions to global healthcare, agriculture, manufacturing and environmental challenges. Moreover, the recent advancements in the field of molecular biology, such as the development of automatic robust chemistries (used for chemical synthesis of DNA) have contributed towards the engineering of biological systems by enabling high-throughput study genomes. Synthetic biology, when combined with sequenced data generated by next generation sequencing (NGS) technology, allows quantitative analysis of RNA and DNA to study the genetic variations associated with the disease or other biological phenomena.

Notably, the spread of the COVID-19 in the past few years has given a significant boost to the development of DNA and RNA-based vaccines to induce potent immune responses in patients. Moreover, customized DNA and RNA synthesis coupled with CRISPR technologies for gene editing and other synthetic biology technologies have demonstrated the potential to change the standard of care for a wide range of disease indications. DNA synthesis technologies not only facilitate parallelized synthesis of DNA but also provide unmatched precision, scalability and speed.

Several companies have developed proprietary enzymatic DNA synthesis platforms offering distinct advantages (such as the potential to increase the length of DNA fragments, greater accessibility and convenience) over conventional DNA synthesis methods. Furthermore, a significant proportion of medical researchers and drug developers prefer to outsource DNA synthesis and replication operations to third-party platforms / service providers who claim to provide expertise in DNA synthesis and production. Given the rising need for DNA across a wide range of applications, we are led to believe that the DNA synthesis and DNA replication platforms and services industry is likely to witness noteworthy market growth during the forecast period.

DNA SYNTHESIS TECHNOLOGIES AND SERVICES MARKET: KEY INSIGHTS

The report delves into the current state of the DNA synthesis technologies and services market and identifies potential growth opportunities within the industry. Some key findings from the report include:

• Around 65 companies presently claim to have the required expertise for DNA synthesis technologies and affiliated services; of these, more than 50% of players are small companies and have recently been established.
• These technology and service providers claim to employ different cost-effective methods for the synthesis of DNA, having applications in various biomedical fields.
• There has been a notable increase in the published scientific literature related to DNA synthesis technologies and services in the last few years; such articles have been published in over 50 countries.

• The growing interest in DNA synthesis technologies and services is reflected by the increase in partnership activity in the recent past; in fact, between 2019 and 2021, the partnership activity increased at a CAGR of 18%.
• Over the past few years, 150 academic grants have been awarded to various organizations in order to support the ongoing efforts related to research and innovation in the field of DNA synthesis technologies.
• Several investors, having realized the future opportunity associated with the DNA synthesis technologies and services market, have invested more than USD 750 million in the past five years.
• More than 11,000 patents have been filed / granted related to DNA synthesis technologies since 2016, establishing a strong portfolio of intellectual property within this industry.
• The DNA synthesis services market is expected to witness an annualized growth rate of more than 21.5% till 2035; the opportunity is likely to be distributed across method of synthesis, application area, company size and geography.

DNA SYNTHESIS TECHNOLOGIES AND SERVICES MARKET: KEY SEGMENTS

Chemical Method Segment Occupies the Largest Share of the DNA Synthesis Technologies and Services Market

Based on the method of DNA synthesis, the market is segmented into chemical method and enzymatic method. At present, the chemical method of DNA synthesis holds the maximum share of the global DNA synthesis technologies and services market. Additionally, the enzymatic method segment is likely to grow at a faster pace owing to the increasing use of enzymes for DNA isolation and synthesis.

By Key Application Area, Therapeutics is the Fastest Growing Segment of the Global DNA Synthesis Technologies and Services Market

Based on the key application area, the market is segmented into research and diagnostics, and therapeutics. Currently, the research and diagnostics segment captures the highest proportion of the global DNA synthesis technologies and services market. It is worth highlighting that the DNA synthesis technologies and services market for therapeutics segment is likely to grow at a relatively higher CAGR.

Large Company Size Segment Occupy the Largest Share of the DNA Synthesis Technologies and Services Market by Company Size

Based on the company size, the market is segmented into small, mid-sized and large companies. At present, the large companies segment holds the maximum share of the DNA synthesis technologies and services market. Further, it is worth highlighting that the DNA synthesis technologies and services market for small companies' segment is likely to grow at a relatively higher CAGR.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Currently, North America dominates the global DNA synthesis technologies and services market and accounts for the largest revenue share.

Example Players in the DNA Synthesis Technologies and Services Market

• Ajinomoto Bio-Pharma Services
• ATUM
• DNA Script
• Eurofins Genomics
• Gene Universal
• GenScript
• Synbio Technologies

DNA SYNTHESIS TECHNOLOGIES AND SERVICES MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global DNA synthesis technologies and services market, focusing on key market segments, including [A] method of DNA synthesis, [B] key application area, [C] company size and [D] key geographical regions.
• Market Landscape: A comprehensive evaluation of DNA synthesis technologies and services, based on several relevant parameters, such as [A] type of offering, [B] method of DNA synthesis, [C] type of DNA molecule, [D] custom offerings and [E] application area. Additionally, the report provides information on drug developers, focusing on [F] year of establishment, [G] company size and [H] location of headquarters.
• Company Profiles: In-depth profiles of key players engaged in providing technologies and services for DNA synthesis, focusing on [A] overview of the company, [B] financial information (if available), [C] technology / service portfolio, and [D] recent developments and [E] an informed future outlook.
• Case Study 1: A detailed discussion on the current market landscape of oligonucleotide manufacturers focused on research and diagnostic applications, based on [A] year of establishment, [B] company size, [C] scale of operation, [D] location of headquarters, [E] number of manufacturing facilities, [F] location of facility, [G] regulatory accreditations and certifications received, [H] type of oligonucleotide manufactured, [I] type of offering, [J] type of manufacturing service(s) offered and [K] type of modification(s) offered.
• Case Study 2: A detailed discussion on the current market landscape of oligonucleotide manufacturers focused on research and therapeutic applications, based on [A] year of establishment, [B] company size, [C] scale of operation, [D] location of headquarters, [E] number of manufacturing facilities, [F] location of facility, [G] regulatory accreditations and certifications received, [H] type of oligonucleotide manufactured, [I] type of offering, [J] type of manufacturing service(s) offered and [K] type of modification(s) offered.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the DNA synthesis technologies and services market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] most active players (in terms of the number of partnerships signed) and [E] geographical distribution of partnership activity.
• Funding and Investment Analysis: An in-depth analysis of the fundings raised by DNA synthesis technologies and services companies, based on relevant parameters, such as [A] year of funding, [B] amount invested, [C] type of funding, [D] leading players, [E] leading investors and [F] geography.
• Grants Analysis: An in-depth analysis of academic grants that have been awarded to various research institutes for projects related to DNA synthesis technologies and services, based on relevant parameters, such as [A] year of grant award, [B] amount awarded, [C] type of funding institute, [D] popular NIH departments, [E] support period, [F] emerging focus area, [G] purpose of grants, [H] grant activity code, [I] local recipients, [J] type of recipient organization, [K] study section and [L] type of grant application. The chapter also highlights the popular recipient organizations and prominent program officers.
• Publication Analysis: An insightful analysis of more than 12,000 peer-reviewed scientific articles related to research on DNA synthesis technologies, based on various relevant parameters, such as [A] year of publication, [B] key focus area, [C] type of article, [D] popular keywords, [E] popular authors, [F] therapeutic area, [G] geography and [H] key journals.
• Patent Analysis: An in-depth analysis of patents filed / granted till date in the autoinjectors domain, based on various relevant parameters, such as [A] publication year, [B] geography, [C] CPC symbols, [D] emerging focus areas, [E] type of applicant, [F] leading industry players and [G] patent valuation.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
• 1.3. Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Introduction to DNA Synthesis
• 3.3. Components of DNA Synthesis
  • 3.3.1. Substrates
  • 3.3.2. Template
  • 3.3.3. Primer
  • 3.3.4. Enzymes
  • 3.3.5. Leading Strand Synthesis
  • 3.3.6. Lagging Strand Synthesis
• 3.4. DNA Synthesis Technologies
  • 3.4.1. Chemical Method of DNA Synthesis
  • 3.4.2. Enzymatic Method of DNA Synthesis
• 3.5. Applications of DNA Synthesis
• 3.6. Future Perspectives

4. MARKET OVERVIEW: DNA SYNTHESIS TECHNOLOGIES AND SERVICES

• 4.1. Chapter Overview
• 4.2. DNA Synthesis Technologies and Services: Overall Market Landscape
  • 4.2.1. Analysis by Type of Offering
  • 4.2.2. Analysis by Method of DNA Synthesis
  • 4.2.3. Analysis by Type of DNA Molecule
  • 4.2.4. Analysis by Custom Offerings
  • 4.2.5. Analysis by Application Area
• 4.3. DNA Synthesis Technologies and Services: Key Industry Players
  • 4.3.1. Analysis by Year of Establishment
  • 4.3.2. Analysis by Company Size
  • 4.3.3. Analysis by Location of Headquarters
  • 4.3.4. Analysis by Application Area and Region

5. COMPANY PROFILES

• 5.1. Chapter Overview
• 5.2. Ajinomoto Bio-Pharma Services
  • 5.2.1. Company Overview
  • 5.2.2. Financial Information
  • 5.2.3. Technology / Service Portfolio
  • 5.2.4. Recent Developments and Future Outlook
• 5.3. ATUM
  • 5.3.1. Company overview
  • 5.3.2. Technology / Service Portfolio
  • 5.3.3. Recent Developments and Future Outlook
• 5.4. DNA Script
  • 5.4.1. Company Overview
  • 5.4.2. Technology / Service Portfolio
  • 5.4.3. Recent Developments and Future Outlook
• 5.5. Eurofins Genomics
  • 5.5.1. Company Overview
  • 5.5.2. Financial Information
  • 5.5.3. Technology / Service Portfolio
  • 5.5.4. Recent Developments and Future Outlook
• 5.6. Gene Universal
  • 5.6.1. Company Overview
  • 5.6.2. Technology / Service Portfolio
  • 5.6.3. Recent Developments and Future Outlook
• 5.7. GenScript
  • 5.7.1. Company Overview
  • 5.7.2. Financial Information
  • 5.7.3. Technology / Service Portfolio
  • 5.7.4. Recent Developments and Future Outlook
• 5.8. Synbio Technologies
  • 5.8.1. Company overview
  • 5.8.2. Technology / Service Portfolio
  • 5.8.3. Recent Developments and Future Outlook

6. CASE STUDY: OLIGONUCLEOTIDE MANUFACTURERES (RESEARCH AND DIAGNOSTIC APPLICATIONS)

• 6.1. Chapter Overview
• 6.2. Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Overall Market Landscape
  • 6.2.1. Analysis by Year of Establishment
  • 6.2.2. Analysis by Company Size
  • 6.2.3. Analysis by Scale of Operation
  • 6.2.4. Analysis by Geographical Location
  • 6.2.5. Analysis by Location of Manufacturing Facilities
  • 6.2.6. Analysis by Regulatory Accreditations / Certifications Received
  • 6.2.7. Analysis by Type of Oligonucleotide Manufactured
  • 6.2.8. Analysis by Type of Offering
  • 6.2.9. Analysis by Type of Manufacturing Service Offered
  • 6.2.10. Analysis by Type of Modification

7. CASE STUDY: OLIGONUCLEOTIDE MANUFACTURERES (THERAPEUTIC APPLICATIONS)

• 7.1. Chapter Overview
• 7.2. Oligonucleotide Manufacturers Focused on Therapeutic Applications: Overall Market Landscape
  • 7.2.1. Analysis by Year of Establishment
  • 7.2.2. Analysis by Company Size
  • 7.2.3. Analysis by Scale of Operation
  • 7.2.4. Analysis by Geographical Location
  • 7.2.5. Analysis by Location of Manufacturing Facilities
  • 7.2.6. Analysis by Regulatory Accreditations / Certifications
  • 7.2.7. Analysis by Type of Oligonucleotide Manufactured
  • 7.2.8. Analysis by Type of Offering
  • 7.2.9. Analysis by Type of Manufacturing Service Offered
  • 7.2.10. Analysis by Type of Modification

8. PARTNERSHIPS AND COLLABORATIONS

• 8.1. Chapter Overview
• 8.2. Partnership Models
• 8.3. DNA Synthesis Technologies and Services: List of Partnerships and Collaborations
  • 8.3.1. Analysis by Year of Partnership
  • 8.3.2. Analysis by Type of Partnership
  • 8.3.3. Analysis by Type of Partner
  • 8.3.4. Analysis by Year and Type of Partner
  • 8.3.5. Most Active Players: Analysis by Number of Partnerships
  • 8.3.6. Regional Analysis
    • 8.3.6.1. Intercontinental and Intracontinental Agreements

9. FUNDING AND INVESTMENT ANALYSIS

• 9.1. Chapter Overview
• 9.2. Types of Funding
• 9.3. DNA Synthesis Technologies: Recent Funding Instances
• 9.4. Analysis by Year of Investment
• 9.5. Analysis by Amount Invested
• 9.6. Analysis by Amount Invested
• 9.7. Analysis by Type of Funding and Amount Invested
• 9.8. Analysis by Venture Capital Funding
• 9.9. Most Active Players: Analysis by Number of Funding Instances
• 9.10. Key Investors: Analysis by Number of Funding Instances
• 9.11. Regional Analysis by Amount Invested
• 9.12. Funding and Investment Summary

10. GRANT ANALYSIS

• 10.1. Chapter Overview
• 10.2. Analysis Methodology and Key Parameters
• 10.3. DNA Synthesis Technologies and Services: List of Academic Grants
  • 10.3.1. Analysis by Year of Grant Award
  • 10.3.2. Analysis by Grant Amount Awarded
  • 10.3.3. Analysis by Administering Institute Center
  • 10.3.4. Analysis by Support Period
  • 10.3.5. Analysis by Administering Institute Center and Support Period
  • 10.3.6. Analysis by Type of Grant Application
  • 10.3.7. Analysis by Grant Activity Code
  • 10.3.8. Word Cloud of Study Titles
  • 10.3.9. Analysis by Purpose of Grant Award
  • 10.3.10. Popular NIH Departments: Analysis by Number of Grants
  • 10.3.11. Analysis by Type of Recipient Organization

10..12. Prominent Program Officers: Analysis by Number of Grants

11. PUBLICATION ANALYSIS

• 11.1. Chapter Overview
• 11.2. Analysis Methodology and Key Parameters
• 11.3. Analysis by Year of Publication
• 11.4. Analysis by Quarterly Distribution of Publication
• 11.5. Analysis by Type of Article
• 11.6. Analysis by Popular Keywords
• 11.7. Most Popular Authors: Analysis by Number of Publications
• 11.8. Popular Publishers: Analysis by Number of Publications
• 11.9. Popular Journals: Analysis by Number of Publications
• 11.10. Analysis by Therapeutic Area
• 11.11. Geographical Analysis

12. PATENT ANALYSIS

• 12.1. Chapter Overview
• 12.2. Analysis Methodology and Key Parameters
• 12.3. DNA Synthesis Technologies and Services: Patent Analysis
  • 12.3.1. Analysis by Type of Patent
  • 12.3.2. Analysis by Publication Year
  • 12.3.3. Analysis by Type of Patent and Publication Year
  • 12.3.4. Analysis by Issuing Authority
  • 12.3.5. Analysis by CPC Symbols
  • 12.3.6. Analysis by Type of Applicant
  • 12.3.7. Word Cloud Analysis: Emerging Focus Areas
  • 12.3.8. Leading Industry Players: Analysis by Number of Patents
  • 12.3.9. Leading Non-Industry Players: Analysis by Number of Patents
  • 12.3.10. Leading Players: Analysis by Number of Patents
  • 12.3.11. Leading Patents: International Patents
  • 12.3.12. Analysis by Patent Characteristics
  • 12.3.13. Patent Valuation Analysis

13. DNA SYNTHESIS SERVICES: MARKET FORECAST AND OPPORTUNITY ANALYSIS

• 13.1. Chapter Overview
• 13.2. Key Assumptions and Forecast Methodology
• 13.3. Global DNA Synthesis Services Market, Till 2035
  • 13.3.1. Global DNA Synthesis Services Market: Distribution by Method of DNA Synthesis, Till 2035
  • 13.3.2. Global DNA Synthesis Services Market: Distribution by Application Area, Till 2035
  • 13.3.3. Global DNA Synthesis Services Market: Distribution by Company Size, Till 2035
  • 13.3.4. Global DNA Synthesis Services Market: Distribution by Geography, Till 2035
• 13.4. DNA Synthesis Services Market in North America, Till 2035
  • 13.4.1. DNA Synthesis Services Market in North America: Distribution by Method of DNA Synthesis, Till 2035
  • 13.4.2. DNA Synthesis Services Market in North America: Distribution by Application Area, Till 2035
  • 13.4.3. DNA Synthesis Services Market in North America: Distribution by Company Size, Till 2035
• 13.5. DNA Synthesis Services Market in Europe, Till 2035
  • 13.5.1. DNA Synthesis Services Market in Europe: Distribution by Method of DNA Synthesis, Till 2035
  • 13.5.2. DNA Synthesis Services Market in Europe: Distribution by Application Area, Till 2035
  • 13.5.3. DNA Synthesis Services Market in Europe: Distribution by Company Size, Till 2035
• 13.6. DNA Synthesis Services Market in Asia-Pacific and Rest of the World, Till 2035
  • 13.6.1. DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Method of DNA Synthesis, Till 2035
  • 13.6.2. DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Application Area, Till 2035
  • 13.6.3. DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Company Size, Till 2035

14. CONCLUDING REMARKS

15. APPENDIX 1: TABULATED DATA

16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

관련자료